Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
19 03 2021
Historique:
received: 16 07 2020
accepted: 18 02 2021
entrez: 20 3 2021
pubmed: 21 3 2021
medline: 10 4 2021
Statut: epublish

Résumé

SARS-CoV-2 is a respiratory pathogen and primarily infects the airway epithelium. As our knowledge about innate immune factors of the respiratory tract against SARS-CoV-2 is limited, we generated and screened a peptide/protein library derived from bronchoalveolar lavage for inhibitors of SARS-CoV-2 spike-driven entry. Analysis of antiviral fractions revealed the presence of α

Identifiants

pubmed: 33741941
doi: 10.1038/s41467-021-21972-0
pii: 10.1038/s41467-021-21972-0
pmc: PMC7979852
doi:

Substances chimiques

Antibodies, Viral 0
Antiviral Agents 0
Immunoglobulin G 0
Serine Proteinase Inhibitors 0
Spike Glycoprotein, Coronavirus 0
alpha 1-Antitrypsin 0
spike protein, SARS-CoV-2 0
Serine Endopeptidases EC 3.4.21.-
TMPRSS2 protein, human EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1726

Références

Rev Med Virol. 2021 Mar;31(2):e2157
pubmed: 32844538
J Virol. 2006 Oct;80(19):9896-8
pubmed: 16973594
J Virol. 2013 Jun;87(11):6150-60
pubmed: 23536651
Am Rev Respir Dis. 1987 Mar;135(3):539-43
pubmed: 3493719
J Biol Chem. 2003 Sep 26;278(39):37881-7
pubmed: 12860985
Clin Microbiol Rev. 2011 Jan;24(1):210-29
pubmed: 21233513
N Engl J Med. 2020 Dec 31;383(27):2684-2686
pubmed: 33326716
Nature. 1982 Jul 22;298(5872):329-34
pubmed: 7045697
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
EBioMedicine. 2020 Aug;58:102925
pubmed: 32745993
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
PLoS One. 2011;6(10):e25858
pubmed: 21998709
J Inherit Metab Dis. 2008 Feb;31(1):21-34
pubmed: 18193338
Respir Res. 2006 Feb 17;7:29
pubmed: 16503962
Am J Med. 1988 Jun 24;84(6A):52-62
pubmed: 3289387
J Clin Invest. 1990 May;85(5):1343-52
pubmed: 2185272
Am J Respir Crit Care Med. 2019 Aug 1;200(3):318-326
pubmed: 30965011
J Virol. 2019 Oct 15;93(21):
pubmed: 31391268
Nat Rev Microbiol. 2014 Oct;12(10):715-22
pubmed: 25110191
J Clin Invest. 1981 Nov;68(5):1158-65
pubmed: 7028785
J Chem Theory Comput. 2020 Mar 10;16(3):1396-1410
pubmed: 32109052
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):453-8
pubmed: 9012804
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
J Virol. 2012 Jun;86(12):6537-45
pubmed: 22496216
Cancer Discov. 2014 Nov;4(11):1310-25
pubmed: 25122198
Front Microbiol. 2020 Apr 06;11:508
pubmed: 32328038
Annu Rev Biochem. 1983;52:655-709
pubmed: 6193754
JAMA. 1988 Sep 2;260(9):1259-64
pubmed: 3261353
Cell Rep Med. 2020 Jul 21;1(4):100059
pubmed: 32835306
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
Biochem J. 2005 Jun 15;388(Pt 3):967-72
pubmed: 15537383
J Virol. 2010 Dec;84(24):12658-64
pubmed: 20926566
Elife. 2020 Apr 02;9:
pubmed: 32228860
Sci Adv. 2019 Apr 10;5(4):eaav4580
pubmed: 30989115
Cancer Res. 2015 Jul 15;75(14):2949-60
pubmed: 26018085
Antimicrob Agents Chemother. 2013 Oct;57(10):4751-60
pubmed: 23856778
Ann Am Thorac Soc. 2016 Aug;13 Suppl 4:S280-8
pubmed: 27564662
Cell Mol Gastroenterol Hepatol. 2021;11(4):935-948
pubmed: 33186749
Cell. 2007 Apr 20;129(2):263-75
pubmed: 17448989
Med Hypotheses. 2021 Jan;146:110394
pubmed: 33239231
Nat Genet. 2008 Jul;40(7):871-9
pubmed: 18552847
Am J Respir Crit Care Med. 2020 Sep 15;202(6):812-821
pubmed: 32584597
PLoS Pathog. 2013;9(12):e1003774
pubmed: 24348248
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
J Clin Invest. 1989 Oct;84(4):1349-54
pubmed: 2794066
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401
COPD. 2013 Dec;10(6):687-95
pubmed: 23862647
J Virol. 2013 May;87(10):5502-11
pubmed: 23468491
Sci Transl Med. 2010 Dec 22;2(63):63re3
pubmed: 21178138

Auteurs

Lukas Wettstein (L)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Tatjana Weil (T)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Carina Conzelmann (C)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Janis A Müller (JA)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Rüdiger Groß (R)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Maximilian Hirschenberger (M)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Alina Seidel (A)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Susanne Klute (S)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Fabian Zech (F)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Caterina Prelli Bozzo (C)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Nico Preising (N)

Core Facility Functional Peptidomics, Ulm University Medical Center, Ulm, Germany.

Giorgio Fois (G)

Institute of General Physiology, Ulm University, Ulm, Germany.

Robin Lochbaum (R)

Institute of General Physiology, Ulm University, Ulm, Germany.

Philip Maximilian Knaff (PM)

Dermatology Clinic, University Medicine Mainz, Mainz, Germany.
Max-Planck-Institute for Polymer Research, Mainz, Germany.

Volker Mailänder (V)

Dermatology Clinic, University Medicine Mainz, Mainz, Germany.
Max-Planck-Institute for Polymer Research, Mainz, Germany.

Ludger Ständker (L)

Core Facility Functional Peptidomics, Ulm University Medical Center, Ulm, Germany.

Dietmar Rudolf Thal (DR)

Laboratory of Neuropathology, Department of Imaging and Pathology, KU-Leuven and Department of Pathology, UZ-Leuven, Leuven, Belgium.
Laboratory of Neuropathology, Institute of Pathology, Ulm University, Ulm, Germany.

Christian Schumann (C)

Pneumology, Thoracic Oncology, Sleep and Respiratory Critical Care Medicine, Clinics Allgäu, Kempten and Immenstadt, Germany.

Steffen Stenger (S)

Institute for Microbiology and Hygiene, Ulm University Medical Center, Ulm, Germany.

Alexander Kleger (A)

Department of Internal Medicine 1, Ulm University Hospital, Ulm, Germany.

Günter Lochnit (G)

Institute of Biochemistry, Justus-Liebig University Giessen, Giessen, Germany.

Benjamin Mayer (B)

Institute for Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.

Yasser B Ruiz-Blanco (YB)

Computational Biochemistry, Center of Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.

Markus Hoffmann (M)

Infection Biology Unit, German Primate Center- Leibniz institute for Primate Research, Göttingen, Germany.
Faculty of Biology and Psychology, Georg-August-University, Göttingen, Germany.

Konstantin M J Sparrer (KMJ)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Stefan Pöhlmann (S)

Infection Biology Unit, German Primate Center- Leibniz institute for Primate Research, Göttingen, Germany.

Elsa Sanchez-Garcia (E)

Computational Biochemistry, Center of Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.

Frank Kirchhoff (F)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Manfred Frick (M)

Institute of General Physiology, Ulm University, Ulm, Germany.

Jan Münch (J)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. jan.muench@uni-ulm.de.
Core Facility Functional Peptidomics, Ulm University Medical Center, Ulm, Germany. jan.muench@uni-ulm.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH